Assessing effects of PFAS exposure from drinking water on hypertension and blood pressure among adults and children using measured and historically reconstructed PFAS blood levels
Active Grant Awarded Last action
- Award ID
- R03ES038312
- Recipient
-
Silent Spring Institute, Inc. UEI CTH5KGL78E65
- Awarding agency
-
National Institute of Environmental Health Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $154,700
Award facts
- Assistance listing
- 93.143 NIEHS Superfund Hazardous Substances_Basic Research and Education
- Completion date 12% complete
- Place of performance
- Newtonville, MA 02460, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Institute of Environmental Health Sciences awarded Silent Spring Institute, Inc. $154,700 on August 27, 2026, under Assistance Listing 93.143, NIEHS Superfund Hazardous Substances_Basic Research and Education (Grant R03ES038312). The recipient will assess associations of measured and historically reconstructed serum PFAS concentrations with blood pressure and hypertension in adults and children, addressing evidence gaps on PFAS mixtures and varying exposures over time. The work builds on data from the ATSDR Multi-Site PFAS Health Study, which includes 6,240 adults and 883 children aged 4 to 17 from communities in eight states with histories of PFAS drinking water contamination. The study is designed with sufficient statistical power to examine effect modification by age, sex, body mass index, and diet. The program supports basic research and training on the public health effects of hazardous substance exposure within the scope of CERCLA and SARA. The period of performance runs from August 27, 2026 through August 27, 2028, with place of performance in Newtonville, MA 02460, USA. The source identifies no sub-recipients for this award.
Description
- Abstract
- Hypertension is a leading cause of cardiovascular disease (CVD) and death globally, affecting nearly 50% of adults in the U.S. And over 1 billion adults worldwide. Annual healthcare costs associated with hypertension are approximately $131 billion in the U.S. The global prevalence of hypertension among children under 18 has increased ~75% from 2000-2015, and hypertension in childhood or adolescence is an important predictor of future CVD and CVD mortality. In addition to well-established risk factors such as poor diet, sodium intake, alcohol consumption, obesity, and lack of physical activity, emerging evidence suggests that exposure to per- and polyfluoroalkyl substances (PFAS) may contribute to hypertension and increased blood pressure in adults and children. However, there are important gaps in the evidence still to address including the importance of quantifying the impact of PFAS mixtures in adults and children and effects of varying exposures over time. Our proposed project will fill these gaps by assessing associations of measured and historically reconstructed serum PFAS concentrations with blood pressure and hypertension among adults and children. We will efficiently build upon data already collected as part of the agency for toxic substances and disease registry (ATSDR) multi- site PFAS health study (MSS), which includes 6,240 adults and 883 children (ages 4-17) from communities in eight states with a history of PFAS drinking water contamination. This study will be one of the largest and most comprehensive epidemiological studies to date and has sufficient statistical power to examine effect modification by age, SEX, body mass index, and diet. Participants provided blood samples and completed body measurements and questionnaires in 2019-2023. Our preliminary results showed associations between measured serum concentrations and increased systolic and diastolic blood pressure among adult participants. We will extend these findings by applying novel study design and statistical methods and, for the first time, time series of historically reconstructed serum PFAS concentrations for adults (back to 2000) and children (back to birth) to assess impacts of PFAS, individually and in mixtures, on blood pressure and hypertension, as well as the influence of the timing of these exposures. We will meet these objectives through two closely related aims: aim 1. Examine associations of historically reconstructed serum PFAS concentrations with blood pressure and hypertension among adults. Aim 2. Examine associations of historically reconstructed and measured serum PFAS concentrations with blood pressure and hypertension among children. Impact: this project will efficiently leverage existing cohorts and address two major gaps in our current understanding of associations between PFAS exposure to blood pressure and hypertension among adults and children. Findings from this study emphasize the importance of reducing PFAS exposure from drinking water and other sources to improve the overall cardiovascular health for both adults and children and can inform future targeted interventions to reduce the risk of high blood pressure, especially in highly exposed communities.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $154,700 |
Quick answers
Who received award R03ES038312?
R03ES038312 was awarded to Silent Spring Institute, Inc. by National Institute of Environmental Health Sciences (National Institutes of Health) on August 27, 2026.
How much is award R03ES038312 worth?
$154,700 has been obligated on R03ES038312.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award